AR and prostate carcinoma: EBP-1 levels are decreased in prostate cancer and restoring EBP-1 levels in a prostate cancer animal model decreases tumorigenicity.[57] EBP-1 expression may be decreased by post-transcriptional up-regulation of androgen receptors.[58]